Akero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	176.03	340.24	234.21	249.77	150.48	187.24
Short-Term Investments	561.79	402.84	315.8	101.68	37.78	81.15
Cash & Short-Term Investments	737.83	743.08	550.01	351.45	188.26	268.39
Cash Growth	2.87%	35.10%	56.50%	86.69%	-29.86%	96.77%
Other Current Assets	16.71	27.3	9.95	3.72	5.32	2.96
Total Current Assets	754.54	770.38	559.96	355.17	193.58	271.35
Net Property, Plant & Equipment	0.55	0.76	1.03	1.29	1.55	1.79
Long-Term Investments	250.49	54.75	19.28	-	-	-
Other Long-Term Assets	-	-	-	0.11	0.42	0.2
Total Assets	1,006	825.89	580.27	356.57	195.55	273.34
Accounts Payable	20.4	9.03	7.04	7.97	6.71	3.43
Accrued Expenses	27.25	30.73	12.09	11.12	18.42	9.68
Total Current Liabilities	47.65	39.75	19.13	19.08	25.13	13.11
Long-Term Debt	-	35.3	24.96	9.54	-	-
Long-Term Leases	0.29	0.53	0.82	1.08	1.31	1.52
Other Long-Term Liabilities	-	0.19	0.05	0.31	-	-
Total Long-Term Liabilities	0.29	36.02	25.84	10.93	1.31	1.52
Total Liabilities	47.94	75.77	44.97	30.01	26.44	14.63
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	2,005	1,575	1,109	748.86	479.44	468.24
Accumulated Other Comprehensive Income	1.83	0.95	0.27	0.04	-0.03	-0
Retained Earnings	-1,049	-826.16	-574.1	-422.34	-310.3	-209.53
Shareholders' Equity	957.64	750.11	535.31	326.56	169.11	258.71
Total Liabilities & Equity	1,006	825.89	580.27	356.57	195.55	273.34
Total Debt	0.29	35.83	25.78	10.62	1.31	1.52
Net Cash (Debt)	737.54	707.25	524.23	340.83	186.95	266.87
Net Cash Growth	4.28%	34.91%	53.81%	82.31%	-29.95%	95.65%
Net Cash Per Share	9.43	10.53	9.97	8.74	5.37	8.48
Book Value	957.64	750.11	535.31	326.56	169.11	258.71
Book Value Per Share	12.24	11.17	10.18	8.38	4.86	8.22
Tangible Book Value	957.64	750.11	535.31	326.56	169.11	258.71
Tangible Book Value Per Share	12.24	11.17	10.18	8.38	4.86	8.22

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q